Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick N Harter

Showing results (91-100 of 205) with videos related to

Pageof 21
Sort By:
Cancers|December 2, 2020
Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 TrialKatharina J Wenger, Marlies Wagner, Patrick N Harter, et al.
Stereotactic and Functional Neurosurgery|April 30, 2014
Confounding factors in diagnostics of MGMT promoter methylation status in glioblastomas in stereotactic biopsiesLutz M Weise, Patrick N Harter, Sebastian Eibach, et al.
Plos One|May 21, 2015
Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain TumorsPatrick N Harter, Lukas Jennewein, Peter Baumgarten, et al.
Journal of Neuro-Oncology|January 20, 2018
Dexamethasone-induced leukocytosis is associated with poor survival in newly diagnosed glioblastomaDaniel Dubinski, Sae-Yeon Won, Florian Gessler, et al.
Cancers|January 28, 2021
Early and Late Postoperative Seizures in Meningioma Patients and Prediction by a Recent Scoring SystemPeter Baumgarten, Mana Sarlak, Daniel Monden, et al.
Neuro-Oncology Advances|January 7, 2026
A novel vascular model yields increased MR perfusion metrics compared to conventional dynamic susceptibility contrast algorithms in untreated glioblastomaJonas Reis, Robert Stahl, Katharina J Müller, et al.
Journal of Neuro-Oncology|July 23, 2025
Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3Jens Blobner, Viktoria Ruf, Jonathan Weller, et al.
Frontiers in Immunology|April 19, 2021
Association of Isocitrate Dehydrogenase (IDH) Status With Edema to Tumor Ratio and Its Correlation With Immune Infiltration in GlioblastomaDaniel Dubinski, Sae-Yeon Won, Maximilian Rauch, et al.
Neuro-Oncology Advances|February 16, 2026
Time matters: The prognostic impact of diagnostic delay on survival in primary central nervous system lymphoma-a single-center, retrospective real-world studyLouisa Lehner, Louisa von Baumgarten, Jonas Reis, et al.
Cell Death & Disease|April 23, 2024
Fatty acid-binding protein 5 is a functional biomarker and indicator of ferroptosis in cerebral hypoxiaHao Peng, Shan Xin, Susanne Pfeiffer, et al.
Pageof 21

Showing results (91-100 of 205) with videos related to

Sort By:
Pageof 21
Cancers|December 2, 2020
Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 TrialKatharina J Wenger, Marlies Wagner, Patrick N Harter, et al.
Stereotactic and Functional Neurosurgery|April 30, 2014
Confounding factors in diagnostics of MGMT promoter methylation status in glioblastomas in stereotactic biopsiesLutz M Weise, Patrick N Harter, Sebastian Eibach, et al.
Plos One|May 21, 2015
Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain TumorsPatrick N Harter, Lukas Jennewein, Peter Baumgarten, et al.
Journal of Neuro-Oncology|January 20, 2018
Dexamethasone-induced leukocytosis is associated with poor survival in newly diagnosed glioblastomaDaniel Dubinski, Sae-Yeon Won, Florian Gessler, et al.
Cancers|January 28, 2021
Early and Late Postoperative Seizures in Meningioma Patients and Prediction by a Recent Scoring SystemPeter Baumgarten, Mana Sarlak, Daniel Monden, et al.
Neuro-Oncology Advances|January 7, 2026
A novel vascular model yields increased MR perfusion metrics compared to conventional dynamic susceptibility contrast algorithms in untreated glioblastomaJonas Reis, Robert Stahl, Katharina J Müller, et al.
Journal of Neuro-Oncology|July 23, 2025
Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3Jens Blobner, Viktoria Ruf, Jonathan Weller, et al.
Frontiers in Immunology|April 19, 2021
Association of Isocitrate Dehydrogenase (IDH) Status With Edema to Tumor Ratio and Its Correlation With Immune Infiltration in GlioblastomaDaniel Dubinski, Sae-Yeon Won, Maximilian Rauch, et al.
Neuro-Oncology Advances|February 16, 2026
Time matters: The prognostic impact of diagnostic delay on survival in primary central nervous system lymphoma-a single-center, retrospective real-world studyLouisa Lehner, Louisa von Baumgarten, Jonas Reis, et al.
Cell Death & Disease|April 23, 2024
Fatty acid-binding protein 5 is a functional biomarker and indicator of ferroptosis in cerebral hypoxiaHao Peng, Shan Xin, Susanne Pfeiffer, et al.
Pageof 21